Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined oral contraceptives, intrauterine devices, progestin-only pills, or subdermal ...

The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in the lining—after studies dating back to 1983 linked high-dose progestin to ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental briefs to Pfizer's summary judgment motion on federal preemption in light of the ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...

The MarketWatch News Department was not involved in the creation of this content. -- Global pharmaceutical company Pfizer Inc. is facing a multidistrict litigation (MDL No.3140) in the USA, currently ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...